zintick

ArriVent BioPharma AVBP

ArriVent BioPharma, Inc. · Nasdaq · Pharmaceutical Preparations

$15.73+2.14%close on Oct. 28, 2026 · volume 989K · Yahoo Finance

Price, last 47 sessions

$20.00$25.00$30.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $31.35 · low $15.09 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 9 →
  • 8-KOct. 26, 2026, 6 a.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

    AI summary, unreviewedArriVent BioPharma (AVBP) Reports 44.8% ORR at 6 mg/kg in Late-Line CRC for Phase 1 ARR-217 ADC

  • 8-KOct. 19, 2026, 8:08 a.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedArriVent BioPharma Publishes FURTHER Phase 1b Firmonertinib Data in Cancer Cell, Reporting 43% and 68% Confirmed ORR in EGFR PACC-Mutant NSCLC

  • SCHEDULE 13GOct. 13, 2026, 4:01 p.m. ETView on SEC.gov
  • 8-KOct. 13, 2026, 6:03 a.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

  • SCHEDULE 13D/AOct. 8, 2026, 6:39 p.m. ETView on SEC.gov
  • 8-KOct. 6, 2026, 8:07 a.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

  • 10-QAug. 12, 2026, 4:20 p.m. ETView on SEC.gov
  • 8-KAug. 12, 2026, 4:07 p.m. ETView on SEC.gov

    Entry into a material definitive agreement · Results of operations and financial condition · Financial statements and exhibits